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Abstract
Black youth account for the largest number of new HIV infections among heterosexual youth. 
Mental illness and difficulties in emotion regulation contribute to increased reports of HIV/
sexually transmitted infection (STI) risk-related sexual behaviors in this group. Yet limited 
interventions exist to address this affective component of the sexual decision-making process. The 
purpose of this paper was to describe the trial design, research challenges, and baseline 
characteristics from a study designed to fill this gap. Project GOLD was a pilot randomized 
controlled trial of a psychoeducational HIV/STI prevention intervention designed to address the 
role of mental illness and emotion regulation in HIV/STI risk among heterosexually-active Black 
youth aged 14 to 17 (N = 108). Challenges encountered in the research process warrant further 
attention in future research (e.g., disagreement among the regulatory bodies on parental 
permission requirements). The most common mental health diagnoses were Recurrent Major 
Depressive Disorder (15.7%) and current substance abuse (7.4%). Participants reported higher 
levels of emotional suppression, and adaptive methods of emotion management, than culturally 
inappropriate expressions of anger or sadness. They also reported a mean age of 13.6 at first 
vaginal sex, used condoms 66% of the time for vaginal sex, and had an average of 3 sexual 
partners in the past 6 months. More than one-quarter (26.9%) had sex with more than one person 
in the same day. These findings indicate intervention is crucial for this population. The 
forthcoming trial evaluation will indicate the promise of such interventions in reducing HIV/STI 
infections in this key population.
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Introduction
Sexually transmitted infections (STIs), including HIV, remain a primary global public health 
concern, especially among our youth. While infections such as Chlamydia and Gonorrhea 
can be cured with medication, the human cost of under treatment and re-infection is 
disconcerting with complications such as infertility and increased susceptibility to HIV 
acquisition (Fleming & Wasserheit, 1999; Mathur, Mullinax, & Santelli, 2017). Moreover, as 
we work to find a cure for HIV, prevention remains a primary tool to curb the epidemic. 
While HIV/STI rates are despairingly high among sexual minorities, rates among 
heterosexual populations also necessitate explicit attention.
Black females aged 13 to 24 in the United States are diagnosed with HIV at a rate 3.8 times 
that of their White counterparts; most of these infections are attributable to heterosexual 
contact (Centers for Disease Control and Prevention [CDC], 2016a). Moreover, Black 
females and males aged 15 to 19 have Gonorrhea rates 11.3 and 16.4 times the rates of their 
White female and male counterparts, respectively (CDC, 2016b). The majority of the work 
with Black males in this demographic focuses on young men who have sex with men—this 
is well justified given that young Black men who have sex with men are currently at the 
epicenter of the HIV epidemic (CDC, 2016a). However, data on young heterosexual Black 
males are increasingly absent from the literature, which hinders our ability to understand and 
design interventions to reduce risk in this demographic. We are not arguing that one 
population should be privileged over another, but rather, joining others to advocate for 
knowledge to continue to be generated for all Black youth given widening HIV/STI 
inequities (Bowleg et al., 2017).
It is well known that Black youth in the United States are disproportionately affected by 
HIV/STIs, yet individual behavior alone cannot fully explain the disparity. In addition to 
sociostructural conditions known to fuel HIV/STI transmission (e.g., poverty, lack of 
comprehensive sexual health education), a growing body of research documents the role of 
factors such as mental illness, psychological distress, and emotion regulation in sexual risk 
behaviors (Braje, Eddy, & Hall, 2015; Brawner et al., 2017; Brown et al., 2017). In other 
words, the psychological sequelae of mental illnesses like depression and anxiety (e.g., 
loneliness, impulsivity), the experience of psychological distress in response to internal 
and/or external conflict, and one’s ability to regulate his/her emotions may affect the 
decisions Black youth make about sex and relationships.
One experiencing depressive symptoms may feel lonely and/or isolated and desire 
connection with another person. While his/her intention may not be to engage in sexual 
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activity, if the person they seek connection with wants to have sex, he/she may decide to 
have sex to achieve connection and mitigate the underlying feelings of loneliness and 
isolation (Brawner, Gomes, Jemmott, Deatrick, & Coleman, 2012). Thus, there is an 
affective component to the sexual decision-making process, wherein the decisions one 
makes about whether or not to have sex, use condoms, etc., is influenced by one’s mood, 
feelings and attitudes. Moreover, data consistently show that Black youth who fall into these 
categories engage in more risk behaviors than their peers, such as non-condom use and an 
increased number of sexual partners (Brawner et al., 2012; Donenberg, Emerson, Brown, 
Houck, & Mackesy-Amiti, 2012; Morrison-Beedy, Grove, Ji, & Baker, 2017). Reports of 
both concurrent and sequential sexual partnerships are also high in this demographic 
(Brawner et al., 2017); such sexual partnerships are noted to more rapidly transmit HIV/STIs 
(Adimora et al., 2013).
Despite these findings, traditional HIV/STI prevention interventions are cognitively based 
and typically do not include affective components. We do not know whether these 
interventions are effective for youth with mental illnesses and/or those who experience 
psychological symptoms or difficulty with emotion regulation. Comparable interventions 
specifically designed for youth experiencing mental illnesses and/or psychological 
symptoms have proven to be effective in decreasing sexual activity and increasing consistent 
condom use (Brown et al., 2014; Brown et al., 2017). Yet so few of these interventions exist. 
The purpose of this paper was to describe the trial design, research challenges, and baseline 
characteristics from a study designed to fill this gap.
Methods
This study was approved by Institutional Review Boards (IRBs) at the University of 
Pennsylvania, the Philadelphia Department of Public Health, and the School District of 
Philadelphia. The participants provided written, informed consent as parental permission 
was deemed not to be required. In Pennsylvania, youth aged 14 and older can legally consent 
to both HIV/STI testing and mental health treatment (Juvenile Law Center, 2006), thus study 
participants met legal age of consent criteria for the research procedures. Despite initial 
disagreements, it was ultimately decided that requiring parental permission would violate 
participants’ rights to privacy and confidentiality, particularly for those whose parents/
guardians where unaware that they were engaging in sexual activity and/or receiving mental 
health treatment. See Brawner and Sutton (2018) for an in-depth discussion of the process 
the research team underwent to reach this determination with assistance from the approving 
IRBs and the Juvenile Law Center (a non-IRB-affiliated youth-legal expert firm in 
Philadelphia).
Design
“Project GOLD: We are Kings and Queens” (Project GOLD) was developed to mitigate the 
relationship between psychological/affective state and sexual risk. The novel program offers 
unique emotion regulation content to address the relationship between mental illness, 
emotion regulation and HIV/STI risk behaviors. A description of the intervention and 
formative research to develop the curricula are published elsewhere (Brawner, Abboud, 
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Reason, Wingood, & Jemmott, under review). The study was a pilot randomized, 
investigator-blind, permuted block trial of a psychoeducational HIV/STI prevention 
intervention. The curriculum was designed to be delivered over two days (three hours per 
day), with eight, 45-minute modules. The face-to-face, group-level format accommodated 
six to eight participants per group. The activities targeted behaviors, as well as cognitive, 
psychological, affective, and social processes associated with HIV/STI risk. Our ultimate 
intent was to design a program that would: a) promote consistent condom use, b) reduce the 
number of sexual partners, c) promote routine HIV/STI testing, and d) promote abstinence 
as an alternative to sex for those who engaged in sexual behavior to meet affective needs.
The study was guided by a psychosocial expansion of the Theory of Planned Behavior 
(Azjen, 1991), nested in a social determinants of health framework. For the 
psychoeducational aspects, we integrated tenets of cognitive behavioral therapy (CBT) to 
help participants solve current problems and modify dysfunctional thinking and behavior 
(Beck, 1976). The intervention was framed in this way to provide a comprehensive 
examination of how factors such as psychological distress, emotion regulation, gender role 
socialization, poverty and attitudes and beliefs toward HIV/STI risk-related sexual behaviors 
influenced HIV/STI risk among Black youth. Black youth aged 14 to 17 were assigned in a 
1:1 allocation ratio, blocking on level of depression severity ascertained by the Patient 
Health Questionnaire-9 (Kroenke, Spitzer, & Williams, 2001) and gender. The aim was to 
estimate the effect of the targeted intervention on consistent condom use (primary outcome), 
sexual activity, the number of concurrent and sequential sexual partners, and laboratory 
confirmed HIV/STIs at 3-, 6- and 12- month follow-up assessments. The two arms were: 1) 
the HIV/STI prevention intervention, or 2) the general health control condition (see Figure 
1). When feasible, HIV/STI prevention and general health cohorts were run in the same 
week (or as close thereafter as possible) to avoid the effect of history bias in participant 
exposures. The intent was to deliver the intervention on site at the community-based mental 
health provider agencies where participants were recruited to explore the feasibility and 
acceptability of the intervention and promote sustainability in community settings should it 
be proven to be efficacious.
Given that the intent was to pilot test the intervention, the focus of statistical analyses was on 
estimation not testing, although testing will be performed in an exploratory manner. Thus, a 
sample of 108 participants was sufficient (HIV/STI prevention arm, n = 52; general health 
control arm, n = 56). An eight-member youth community advisory board, comprised of 
members of the target demographic, oversaw the study activities and provided feedback on 
the investigators’ interpretations. The youth were recruited from local community-based 
mental health providers and high schools by flyers and word of mouth; parents/guardians 
provided signed letters of permission for their attendance at meetings. The “Project GOLD” 
title was initially devised from the investigators’ interpretations of the study’s preliminary 
data. The youth community advisory board agreed with the nomenclature and endorsed its 
cultural relevance. GOLD is not an acronym, but rather reflects the youth community 
advisory board’s request to capitalize the letters to emphasize “royalty and self-worth” in the 
intervention.
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Recruitment and eligibility criteria
The study was conducted in Philadelphia, PA where rates of heterosexual HIV transmission 
remain high (Philadelphia Department of Public Health, 2017). Recruitment for the pilot 
randomized controlled trial (RCT) occurred from August 2014 through September 2016. 
The target sample size was 128 (n = 64 in each arm). We enrolled participants on an ongoing 
basis, completing 3-, 6- and 12-month follow-up assessments. Participants were initially 
recruited from a variety of sources including community-based mental health providers, high 
schools, community partners (e.g., recreation centers) and provider referrals.
Inclusion criteria were: 1) aged 14 to 17 years old, 2) self-identify as Black (inclusive of 
African American, Caribbean-American, etc.), 3) currently receiving outpatient psychiatric 
services from a community-based mental health provider, 4) have been at client at the 
participating community-based mental health provider for at least one month, 5) have had 
vaginal sex in the past 3 months (given the focus on heterosexually active youth), 6) able to 
provide signed informed consent, 7) able to speak, read, and write in the English language, 
and 8) plan to be in the Philadelphia area for the next 12 months (see Table 1). Participants 
were excluded for cognitive deficits that would limit their ability to complete the study 
procedures (i.e., active psychosis, developmental disability; this was assessed by trained staff 
at the time of screening), active suicidality or if they had unstable contact information (i.e., 
no land line/mobile phone; this was done for intervention scheduling purposes).
Recruitment challenges and strategies to resolve them
The original intent was to explicitly focus the sample to youth currently receiving outpatient 
mental health treatment by targeting recruitment in community-based mental health 
providers. However, we encountered several barriers which substantially delayed accrual, 
necessitating expansion of the inclusion criteria to accomplish the study aims. These 
challenges also required additional partnerships with outside agencies and changes to the 
original study protocol to meet the research objectives.
First, there was a protracted, 14-month timeline for full review and approval of the protocol. 
The study required approval by multiple entities, including the funding source, all of which 
did not agree on the proposed protocol implementation with this vulnerable population. The 
need for parental permission and conducting HIV testing without notifying parents/
guardians were primary sources of concern. At the request of the local IRBs, we contacted 
the Juvenile Law Center to conduct a youth-focused third-party review of the protocol to 
help support a decision. The attorneys provided the service free of charge and concluded that 
the study’s consent provisions were consistent with the Mental Health Procedures Act and 
the Health Information Portability and Accountability Act; see (Brawner & Sutton, 2018). 
Second, at the time of enrollment the census for the target demographic at the ten partnering 
provider sites was relatively low, and some agencies only had one Black youth who met the 
preliminary screening criteria—the intervention was designed to be delivered in groups of 
six to eight. Our community partners at these sites described how the client demographics 
fluctuated on a monthly, and sometimes weekly, basis, which led to the discrepancy between 
the number of potential participants presumed to be in care and those actually on site at the 
time of recruitment. Lastly, given high mental health acuity and social burden among some 
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members of the target population, some of the interested participants could not be reached 
for enrollment due to concerns including incarceration, foster home placement, unstable 
contact information (for both participants and their designated contacts) and multiple 
competing demands (e.g., last minute shifts for work, responsibilities to care for their own 
children and/or siblings).
Thus to accomplish the study aims with an adequate sample, we made three primary changes 
to the study protocol: 1) the intervention sessions were run at the first author’s institution, 
bringing youth together across multiple sites to meet the minimum group size of six, 2) the 
recruitment approach was modified to include online and social media study promotion, as 
well as face-to-face recruitment at public venues (e.g., concerts, transportation stops, 
shopping centers) to reach a broader audience, and 3) the inclusion criteria were expanded to 
include Black youth regardless of mental health diagnosis or treatment status. The modified 
inclusion criteria are highlighted in Table 1.
We expanded the inclusion criteria under the philosophy of a “walking well” theory derived 
from our decade-long research with the target demographic. In this work, we have noted that 
many of Philadelphia’s Black youth are exposed to multi-level stressors (e.g., limited 
educational and community resources, trauma, violence, poverty). Some of these youth do 
not experience any adverse psychological or emotional effects of these stressors. Others, 
who we consider to be the “walking well”, experience psychological distress and struggle to 
regulate their emotions in the face of these stressors but are not engaged in clinical treatment
—and sometimes do not desire to do so because of stigma or prior negative experiences with 
mental health treatment. Further, we believe that there are youth who: 1) meet clinical 
criteria for psychiatric diagnoses but have not been screened and/or engaged in care, or 2) 
experience clinically significant/meaningful levels of psychological distress that are not 
captured by our current screening practices because the measures have not been normalized 
in samples with adequate representation of Black youth. Thus, we expanded the inclusion 
criteria presuming that youth who were not in care faced similar multi-level stressors as 
those in care, and may have comparable psychological and emotional symptom experiences. 
Moreover, and in line with other researchers in this area, we believe that it is these affective 
concerns (e.g., sadness, impulsivity, guilt), not solely the clinical diagnosis of a mental 
illness, that increase HIV/STI risk among Black youth.
Resultantly, within each intervention condition there were youth who were recruited from 
community-based mental health providers (in treatment) and the general community (not in 
treatment). To ensure accurate categorization of participants’ outpatient mental health 
treatment status for the analyses, those recruited from general community locations were 
asked whether or not they were currently receiving mental health treatment, and if so, the 
name of the program. Those who self-reported current treatment were categorized in the 
community-based mental health provider group. The protocol modification enables us to 
report on the number of youth in and out of care who meet clinical diagnostic criteria for 
mental illnesses, as well as those experiencing psychological distress and trouble with 
emotion regulation.
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Procedures
Interested participants were screened for eligibility by telephone or in person using a 
structured screening script. Those meeting these preliminary inclusion criteria were 
scheduled for the diagnostic assessment visit. At Visit 1, participants consented and 
underwent a structured diagnostic interview using the MINI Neuropsychiatric Interview 
(Sheehan et al., 1998) to determine clinical diagnosis, if any, and to rule out exclusionary 
conditions. Those ineligible after the MINI were thanked for their time and not included in 
the study.
Those eligible immediately underwent a structured demographic interview (e.g., age, 
physical health history, personal and family mental health history), provided detailed locator 
information so that we could follow them longitudinally (e.g., persons aged 18 and older 
who could contact them, locations where they socialized), were randomized to their 
intervention condition and were scheduled for Visit 2. At Visit 2, participants completed the 
baseline survey (e.g., Child Emotion Management Scale [Zeman, Shipman, & Penza-Clyve, 
2001], sexual risk attitudes and behaviors), provided a urine sample for Chlamydia and 
Gonorrhea testing, and received the Session 1 intervention content. They returned for 
intervention Session 2 two weeks later where they received the final intervention content, 
completed the immediate post survey (e.g., CEMS, sexual risk attitudes), received a resource 
guide with key curriculum elements to reinforce the messaging, and were offered to have 
their mouths swabbed for HIV testing.
There was a “Rites of Passage” Ceremony at the end of Session 2 to celebrate participants’ 
completion of the intervention and investment in preserving their sexual health. Participants 
then returned at 3-, 6-, and 12-months to repeat the study measures and HIV/STI testing. 
Figure 2 shows the study visit diagram. As compensation, participants could receive up to 
$200 over the one-year study period. They received $65 after the second intervention 
session, and then $30, $45, and $60 respectively for the 3-, 6-, and 12-month follow-up 
visits. No compensation was provided for Visit 1 as this visit was used to determine RCT 
eligibility. The follow-up incentive amount was increased over time to facilitate retention.
Given the extensive protocol delays, it was not feasible to follow each participant through 
the 12-month follow-up as stated in the original study timeline. The funding agency agreed 
to provide a 12 month “low-cost” extension to facilitate accomplishment of the study aims. 
In a low-cost extension, a limited amount of funds is provided to support the research (e.g., 
participant compensation, staff salaries) in addition to extending the time period for the 
research activities (e.g., enrollment, data cleaning and analyses). Thus instead of the trial 
ending in December 2015, it ended in December 2016. At the funder’s request, we 
continued intervention delivery until September 2016 which allowed for the enrollment of 
more participants into the trial, while also ensuring time to collect at least 3-month follow-
up data to facilitate examination of the intervention effects. Consequently, conclusions to be 
drawn from the 6- and 12-month follow-up data will be limited as those samples are 
substantially smaller.
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Laboratory testing procedures
For Chlamydia and Gonorrhea testing, 15 to 20 cubic centimers of urine were collected from 
each participant and transferred to Aptima tubes® for transport and testing by the 
Philadelphia Department of Public Health. Results were reported to the study’s ordering 
physician via secure fax, and the study nurse practitioner contacted participants to notify 
them of their STI status. Those who tested positive were encouraged to receive free 
treatment through the local Health Department or from their primary care provider; 
authorization for medical release was signed at the time of consent to confirm treatment. 
Those who could not be reached or did not receive treatment were referred to the 
Philadelphia Department of Public Health STD Control Program as required by local 
statutes. HIV testing was performed as an oral swab by our AIDS Service Organization 
partner using the OraQuick ADVANCE® Rapid HIV-1/2 Antibody Tests. This was a 
feasibility portion of the study thus HIV testing was not required for participation. The 
protocol indicated that positive results would be sent for confirmatory testing and then 
linked to care in accordance with the partnering AIDS Service Organization’s policies and 
procedures.
Data collection and analysis
The study measures are presented in Table 2. Of note, the depression assessment (Patient 
Health Questionnaire-9; PHQ-9) and two of the emotion management scales (anger and 
sadness dysregulation) demonstrated minimally acceptable reliability with Cronbach’s α 
ranging from .51 to .65. This may reflect the fact that the normative sample used to develop 
these measures was different from the population included in the RCT, and also supports our 
supposition that some Black youth experience and express psychological distress differently 
than the general population (i.e., depression manifesting as anger and not sadness). 
Computer-assisted personal interviews (CAPI) were used to collect the demographic and 
behavioral data which were managed in Questionnaire Design Studio® data warehouse. 
Study visit information and HIV/STI data were managed in FileMaker Pro 12.
For this paper, descriptive statistics were used to characterize demographic, mental health 
and emotion regulation, and sexual risk variables at baseline. Means, standard deviations, 
medians, and interquartile ranges (IQR) were used to describe continuous variables, and 
frequencies and percentages were used to describe categorical variables. Chi-square or 
Fisher’s exact tests were used to examine differences in demographic, mental health and 
emotion regulation, and sexual risk variables between participants in the HIV and general 
health conditions; differences between participants currently receiving treatment from 
community-based mental health providers or members of the general community within the 
assigned conditions were also examined. Two-sample t-tests were used to compare normally 
distributed continuous variables across the two groups; nonparametric Wilcoxon Mann-
Whitney tests were used to compare non-normally distributed continuous variables. 
Statistical significance was taken at the 0.05 level, recognizing that the intent of this work 
was to describe differences in characteristics by group. All analyses were accomplished 
using SAS Version 9.4 (SAS, 2013). To evaluate the RCT, we will measure change from 
baseline in consistent condom use (primary outcome), the number of sexual partners, and 
laboratory confirmed HIV/STIs.
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Results
A total of 109 participants were eligible. One participant presented with imminent suicide 
risk at the baseline visit (on completion of the PHQ-9 right before the start of the 
intervention session). This individual was escorted for emergency evaluation and was 
discontinued from the trial in accordance with the study protocol. The final RCT sample was 
108. Fifty-two participants (48.1%) were assigned to the HIV condition, and the remaining 
56 (51.9%) were assigned to the general health condition. Demographics, sexual risk 
characteristics, and mental health and emotion regulation of the sample by intervention 
condition are presented in Tables 3 and 5. Tables 4 and 6 highlight the findings, broken 
down by intervention condition and whether participants were currently receiving treatment 
from community-based mental health providers or members of the general community. The 
mean participant age was 15.8 years (SD = 0.97; see Table 3). Most were male (62.0%) and 
lived in a house that their parent/guardian owns or rents (87%). There was an average of 2 
(SD = 1.13) adults and 3 (SD = 1.85) children per household. More than half (55.6%) 
believed their family income was about the same as other people they knew. There were no 
statistically significant demographic differences between the intervention conditions (see 
Table 3), or between those in mental health treatment versus those in the general community 
(see Table 4).
Sexual risk
On average, participants were 13 to 14 years old at their first sexual encounter (see Table 3). 
The large majority reported using condoms sometimes (41.7%) or every time (40.7%) they 
had sex in the past 3 months; the mean proportion of condom use for vaginal and anal sex 
was 0.7 (SD = 0.40), and 0.6 (SD = 45), respectively. The lowest proportion of condom use 
was reported for oral sex (Mean [M] = 0.1; SD = 0.34). Participants reported a median of 4 
(Interquartile range [IQR] = 2.0, 6.0) vaginal and 3 (IQR = 2.0, 5.0) oral sex partners, and a 
median of 1 (IQR = 1.0, 2.0) anal sex partner since initiating sexual intercourse. About one 
in three participants (34.3%) reported sexual partner concurrency—having sex with someone 
while already in a sexual relationship with someone else—with a median of 2 (IQR = 2.0, 
3.0) lifetime concurrent sexual partner encounters. Nearly half (45.4%) endorsed having sex 
with more than one person in the same month, and 26.9% reported having sex with more 
than one person in the same day. Forty-four percent had ever been tested for HIV. Almost 
one in ten (9.3%) tested positive for Chlamydia; one person (0.9%) tested positive for 
Gonorrhea.
Participants in the general health condition were significantly more likely to report having 
sex with more than one person in the same month (55.4% vs. 34.6%, p = 0.02; see Table 3) 
than those in the HIV condition. For the HIV condition (see Table 4), compared to those in 
mental health treatment, those in the general community: were younger at first anal sex 
(Mage = 13 [SD = 1.62] vs. Mage = 15 [SD = 0.50], p = 0.03); used condoms more frequently 
in the past 3 months (p = 0.01), including a higher proportion of condom use for oral sex (M 
= 0.3 [SD = 0.48] vs. M = 0 [SD = 0.00], p = 0.01); and had fewer reports of prior HIV 
testing (33.3% vs. 64.0%, p = 0.03). For the general health condition, compared to those in 
mental health treatment, those in the general community: had fewer oral sexual partners (M 
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= 3.8 [SD = 6.81] vs. M = 8.6 [SD = 6.09], p = 0.001); and a higher proportion of condom 
use for vaginal sex (M = 0.8 [SD = 0.33] vs. M = 0.5 [SD = 0.41], p = 0.04).
Mental health and emotion regulation
The primary diagnoses were depressive disorders and current substance abuse (see Table 5). 
The average PHQ-9 score was 2.9 (SD = 2.95), indicating no depression in the past two 
weeks. Three percent self-reported suicidal ideation on the PHQ-9 (“Thinking that you 
would be better off dead or that you want to hurt yourself in some way”) and were assessed 
for suicide risk using the Columbia Suicide Severity Rating Scale (Posner K, 2008). 
However, participants in the general health condition were significantly more likely to meet 
criteria for suicidality on the MINI compared to those in the HIV condition (23.2% vs. 7.7% 
respectively, p = 0.03). For the HIV condition (see Table 6), compared to those in the general 
community, participants at community-based mental health providers reported a higher 
PHQ-9 score (M = 4.0 [SD = 2.75] vs. M = 2.4 [SD = 2.71], p = 0.03). Additionally, for the 
general health condition, compared to those in the general community, more participants at 
community-based mental health providers had low suicidality ranks (36.0% vs. 9.7%, p = 
0.03; see Table 6). While not statistically significant, more participants in the general 
community met diagnostic criteria for conditions such as current Panic Disorder without 
agoraphobia (2 vs. 1, p >.99, HIV condition), past Major Depressive Disorder (3 vs. 2, p > .
99, general health condition), recurrent Major Depressive Disorder (4 vs. 1, p = 0.35, HIV 
condition; 8 vs. 4, p = 0.52, general health condition) and current substance abuse (4 vs. 0, p 
= 0.11, HIV condition).
On the CEMS, participants on average reported higher anger coping (M = 2.2; SD = 0.48) 
than inhibition (M = 2.0; SD = 0.52) or dysregulation (M = 1.7; SD = 0.56). Similarly, the 
average for sadness coping (M = 2.3; SD = 0.49) was higher than sadness inhibition (M = 
2.1; SD = 0.61) or dysregulation (M =1.4; SD = 0.47). Altogether, this indicates higher 
levels of adaptive methods of emotion management, as well as emotional suppression, than 
culturally inappropriate expressions of anger or sadness. Of note, in comparing the two 
emotions, there was more dysregulation of anger than sadness (M = 1.7; SD = 0.56 vs. M = 
1.4; SD = 0.47). There were no statistically significant differences between those in the HIV 
and general health conditions, or in mental health treatment versus those in the general 
community on the emotion regulation variables.
Discussion
The influence of affective processes (e.g., sadness, impulsivity) on the decisions individuals 
make about sexual behaviors is well documented. Yet few interventions exist that merge 
evidence-based HIV/STI prevention strategies (e.g., sexual partner negotiation skills) with 
psychological strategies (e.g., Cognitive Behavioral Therapy techniques) to reduce HIV/STI 
risk. Black youth at risk for HIV/STIs were successfully enrolled into a pilot RCT of a 
psychoeducational HIV/STI prevention intervention specifically designed to address the role 
of mental illness and emotion regulation in HIV/STI risk. The sample included an 
underserved population largely absent from HIV/STI prevention literature—Black youth 
receiving outpatient mental health treatment.
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Participants reported several behaviors that increased their risk for HIV/STIs. In comparing 
our sample to other Black, heterosexual high school-aged youth in Philadelphia, we noted 
that our participants engaged in more risk behaviors than their counterparts (CDC, 2018). 
The reports of concurrent sexual partners are most concerning. Moreover, 10% of the sample 
tested positive for an STI. Among participants in the HIV condition, those from the general 
community sample also had fewer reports of prior HIV testing. While we are unable to 
definitively explain this finding, we do know that Philadelphia providers have established 
unique partnerships where AIDS service organizations provide on-site HIV testing at 
community-based mental health provider programs. Thus increased HIV testing within the 
mental health sample may reflect success of these efforts, as well as the benefits of 
integrating mental health and physical health services, especially for youth. Additional 
efforts are needed toward novel integration of HIV/STI prevention programming and mental 
health treatment to reduce HIV/STI risk among Black youth, including those with mental 
illnesses or other affective concerns (Brawner et al., 2017). Reports of condom use in our 
sample, however, were relatively high. More than 80% reported using condoms sometimes 
or every time they had sex in the past 3 months. While 100% condom use would be ideal to 
prevent HIV/STIs, these numbers are encouraging and can continue to be reinforced in 
intervention content. The key will be to promote continued condom use when relationship 
dynamics change, as researchers note condom use diminishes as trust develops and/or youth 
“fall in love” (Teitelman, Tennille, Bohinski, Jemmott, & Jemmott, 2011).
In some instances, participants in the general community reported more mental health 
concerns and sexual risk behaviors than those in mental health treatment. This supports our 
“walking well” theory that there are Black youth in the general population who may 
experience psychological symptoms, along with the resultant sexual risk consequences of 
those symptoms. We believe that the components of Project GOLD that were designed to 
address affective components of the sexual decision-making process (e.g., sadness leading to 
condomless sex to relieve emotions) may be beneficial to the larger population of Black 
youth, regardless of mental health treatment status. Additionally, the averages for anger 
dysregulation were higher than those for sadness dysregulation, indicating that some Black 
youth may have more culturally inappropriate expressions of anger than sadness. This aligns 
with our postulation that the experience of psychological symptoms may manifest 
differently in some populations, calling for additional considerations in our mental health 
screening, diagnosis and treatment procedures. Moreover, inhibition/suppression of anger 
and sadness among Black youth should be attended to to prevent future complications (Folk, 
Zeman, Poon, & Dallaire, 2014).
Reports of suicidal ideation also warrant further attention. Nearly one in four participants in 
the general health condition met clinical criteria for suicidality. In the overall sample, 3% 
reported suicidal ideation in the past 2 weeks, and 16% met clinical criteria for suicidality. 
Researchers report that some Black youth encounter multiple stressors, such as community 
violence and underfunded educational systems, yet often do not have adequate resources to 
help buffer against those stressors (Jones & Neblett, 2017; Turner, Shattuck, Hamby, & 
Finkelhor, 2013). This may lead to subclinical presentations of psychological distress or 
trouble with regulating emotions. Additionally, mental illnesses are often underdiagnosed or 
misdiagnosed by providers in this population, with stark disparities in receipt of treatment 
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(Brawner & Waite, 2009; Lindsey, Chambers, Pohle, Beall, & Lucksted, 2013). Or, Black 
youth and/or their families may have different conceptions about mental illnesses and their 
treatment (Paidipati, Brawner, Eiraldi, & Deatrick, 2017). Suicide risk assessment and 
intervention is an important consideration for those working with Black youth.
For others working with this demographic, it is important to note that we encountered 
substantial time delays and difficulties recruiting a clinical sample for this research. Part of 
the delay came from working with multiple IRBs that did not all agree on the study protocol; 
several others have faced similar challenges (Kaur, 2013; Mammel & Kaplan, 1995). In 
Brawner and Sutton (2018), we provide an in-depth description of the IRB challenges faced 
and measures undertaken to resolve them; this publication may be particularly useful for 
individuals conducting sexual health research with youth and/or making determinations 
about the necessity of parental consent waivers. Partnering with a non-IRB affiliated youth 
legal expert was a novel strategy (suggested by the local IRBs), and helped reach resolution 
to move the research forward. The scientific, legal, and ethics communities must continue to 
partner together to ensure an adequate balance between knowledge development and human 
subjects protections.
Additionally, we were fortunate that a low-cost extension was granted to facilitate our ability 
to accomplish the study aims. When resources are available, it is crucial that researchers 
receive adequate time and funding to conduct community-engaged research. These projects 
typically require extensive time commitments and can often experience unforeseen delays 
(Ross et al., 2010), such as those described in this paper. This is particularly true when 
investigators undergo iterative processes to incorporate input from the target community, 
which can change planned study procedures. In our case, our youth advisors and participants 
in our preliminary work repeatedly indicated that parental permission requirements would be 
a barrier to their participation, thus we staunchly advocated for them despite the encountered 
delays.
Another barrier was identifying members of the target population who were actively 
engaged in mental health treatment. Our key stakeholders, including community-based 
mental health program directors and frontline staff, attributed the low census of youth in the 
target demographic to a trend in local behavioral health treatment where they are able to 
actively engage and retain children and adults, but struggle with youth. Other researchers 
have discovered that stigma, patient-provider relationships, and the quality of mental health 
services are barriers to mental health care, including among youth (Brawner & Waite, 2009; 
Substance Abuse and Mental Health Services Administration, 2015). Lastly, some Black 
youth in Philadelphia face substantial psychological and social challenges that interfere with 
their daily lives along with their ability to participate in longitudinal research studies. Many 
were interested in the study and believed participation would be beneficial for themselves 
and/or others, however, factors such as criminal justice system involvement, family conflict 
leading to foster care placement, childcare responsibilities, and employment demands were 
barriers to participation. This is similar to what others conducting research with racial/ethnic 
minorities have discovered (George, Duran, & Norris, 2014). With advances in social media 
and online research, innovative online strategies can be implemented to ensure that study 
samples include populations that may have difficulty attending in-person study visits, as well 
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as to deliver intervention content to these groups (Stevens et al., 2017). Such generation of 
new knowledge from underserved populations and convenient dissemination of effective 
intervention strategies to these groups may help to reduce HIV/STI disparities.
In expanding the inclusion criteria, we will be able to analyze our “walking well” theory. 
The baseline data, however, support the theory given that there were no statistically 
significant differences in mental health diagnoses between the community-based mental 
health provider and general community groups; the expectation would have been to see 
significant differences if one presumed that fewer general community youth would meet 
diagnostic criteria. However, in some instances, more participants from the general 
community met diagnostic criteria for different conditions (e.g., Recurrent Major Depressive 
Disorder) than those in mental health treatment. By including a spectrum of Black youth, 
from the psychologically and emotionally healthy to those receiving outpatient mental health 
treatment for clinical diagnoses, we will be able to determine whether targeting HIV/STI 
prevention intervention content to incorporate affective needs is a beneficial strategy for 
Black youth. With this change, however, we will have to explore intervention effects by 
mental health diagnosis and treatment status in the longitudinal analyses. It is also 
interesting that participants had high levels of adaptive methods of emotion management co-
occurring with emotional suppression. One might have expected to see lower levels of 
emotional suppression among individuals with more adaptive methods to cope with their 
emotions. This paradox calls to question whether participants’ chosen coping methods were 
health promoting (e.g., exercise to relieve stress) or detrimental (e.g., drug/alcohol 
consumption, sex to relieve stress) as surmised in previous research (Brawner et al., 2017).
Conclusions
A sample of 108 heterosexually-active Black youth participated in a pilot RCT of a 
psychoeducational HIV/STI prevention intervention. The novel intervention contributes to 
HIV/STI prevention science by addressing affective components of the sexual decision-
making process. The number of positive STI diagnoses at baseline, alongside participants’ 
reports of HIV/STI risk-related sexual behaviors, indicate the need for further intervention 
with this demographic. Given the association between mental illness, emotion regulation, 
and sexual risk behaviors, such intervention programs may be effective ways to reduce 
HIV/STI transmission for this key population. Pending the results of the forthcoming pilot 
study evaluation, we plan to test Project GOLD in a larger efficacy trial. If the face-to-face, 
group-level format proves to be effective, future adaptations can leverage technologically for 
online delivery to engage hard-to-reach demographics and a broader audience of Black 
youth at risk for HIV/STIs.
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Figure 1. 
Study design. This figure illustrates the study design and flow of participants through the 
study activities. Note. PHQ-9 = Patient Health Questionnaire-9; CAPI = computer-assisted 
personal interview.
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Figure 2. 
Study visit diagram. This figure illustrates the timeline of the participants’ study visits, and 
the activities completed at each visit. Note. PHQ-9 = Patient Health Questionnaire-9.
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Table 1.
Original and Modified Inclusion and Exclusion Criteria
Original Modified
Inclusion 
Criteria
Aged 14 to 17 years old
Self-identify as Black (inclusive of African American, Caribbean, Kenyan, etc.)
Currently receiving outpatient psychiatric services from a community-based mental health provider Removed
Have been a client at the participating community-based mental health provider for at least 1 month Removed
Have had vaginal sex in the past 3 months Changed to “have 
ever had vaginal sex”
Able to provide signed informed consent
Able to speak, read and write in the English language
Plan to be in the Philadelphia area for the next 12 months
Exclusion 
Criteria
Diagnosis of a psychotic disorder (i.e., Schizophrenia) or a disorder with psychotic features
Cognitive deficit that would impair ability to complete study procedures
Actively suicidal (PHQ-9 item #9 rating of 1, 2 or 3 with plan and intent) or requiring hospitalization
Unstable contact information (homeless or no permanent address, or no land line or mobile phone)
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Table 2.
Project GOLD Study Measures
Variable(s) Measurement Description
Demographics Investigator items Demographic data collected included age, gender, current residence, grade in school and 
socioeconomic indicators (e.g., perceived family income compared to others).
Mental Health and Emotion Regulation
Psychiatric 
Diagnosis
The Mini-International 
Neuropsychiatric 
Interview (M.I.N.I.) 
English version 6.0.0
Sheehan et al., 1998
The MINI served as the primary instrument for diagnostic case ascertainment. The fourteen 
module instrument is a short structured diagnostic interview for Diagnostic and Statistical 
Manual of Mental Disorders psychiatric disorders (APA, 2000) which takes about 30 minutes 
to complete; the study began before the DSM-V was available. Advanced research assistants 
were trained to conduct the structured interviews.
Depression 
Screening
Patient Health 
Questionnaire-9 
(PHQ-9)
Kroenke et al., 2001
The Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report depression assessment 
with acceptable reliability, validity, sensitivity, and specificity, and is a useful tool in provider 
recognition of major depression in addition to subthreshold depressive disorders (Lowe, 
Kroenke, Herzog, & Grafe, 2004; Martin, Rief, Klaiberg, & Braehler, 2006). The instrument 
scores each of the 9 DSM-IV depression diagnostic criteria as “0” (not at all) to “3” (nearly 
every day). Total scores range from 0 to 27, and depression severity is assessed as follows: 0–
4= “none”, 5–9= “mild depression”, 10–14= “moderate depression”, 15–19= “moderately 
severe depression”, and 20–27= “severe depression”. The instrument had minimally 
acceptable reliability in the current study (Cronbach’s α= .65).
Suicidal Ideation 
and Intention
Columbia-Suicide 
Severity Rating Scale 
(C-SSRS)
Posner et al., 2008
Suicidal ideation and intention were determined from the Columbia-Suicide Severity Rating 
Scale (C-SSRS). The C-SSRS is a brief, low-burden clinician-administered questionnaire 
designed to assess and track suicidal ideation and behavior (e.g., suicide attempts, wish to die, 
thoughts of suicide, plan and intent). The tool is widely used in clinical research and is 
recommended by the FDA to assess suicidality in clinical trials. All participants who 
endorsed suicidal ideation on the PHQ-9 were assessed using the C-SSRS.
Emotion 
Regulation
The Children’s Emotion 
Management Scale 
(CEMS)
Zeman et al., 2001
The Children’s Emotion Management Scale (CEMS) was used to assess self-reported sadness 
(11 items) and anger (12 items) management. The Likert scale ranked items as 1 (hardly 
ever), 2 (sometimes), or 3 (often) in response to three subscales for: 1) Inhibition, emotional 
suppression (e.g., “I get sad inside but I don’t show it”); 2) Dysregulated Expression, 
culturally inappropriate emotional expression (e.g., “I say mean things to others when I am 
mad”); and 3) Emotion Regulation Coping, adaptive methods of emotion management (e.g., 
“When I am feeling sad, I do something totally different until I calm down”). Higher scores 
reflect more of the construct. The Cronbach’s α in this sample were acceptable (with the 
exception of the anger and sadness dysregulation subscales): anger inhibition (.71), anger 
dysregulation (.63), anger coping (.70), sadness inhibition (.80), sadness dysregulation (.51), 
and sadness coping (.69).
Sexual Risk
Proportion of 
Condom Use
Investigator item Continuous variable calculated by dividing the number of intercourse acts with condoms by 
the total number of intercourse acts. This measure of consistent condom use was calculated 
independently for each type of sexual act (e.g. vaginal, anal and/or oral sex).
Number of Sexual 
Partners
Investigator items Continuous variables calculated in response to a question about the number of sexual partners 
participants had in the past 3-, 6- and 12-months. Sexual partner concurrency was also 
measured as a dichotomous variable in response to questions about whether they had sex with 
more than one person in the same month and/or day, and if they had sex with someone while 
already in a sexual relationship with someone else. There was also a continuous measure of 
the number of times they had sex with someone while already in a sexual relationship with 
someone else.
Laboratory 
Confirmed HIV/
STIs
DNA amplification tests 
on urine specimens
OraQuick ADVANCE® 
Rapid HIV-1/2 Antibody 
Tests
Dichotomous variable. Diagnosis of Chlamydia trachomatis (CT) and Neisseria gonorrhea 
(GC) was made based on DNA amplification tests on urine specimens. Participants provided 
an on-site first-void urine specimen of approximately 15 to 20 cc. Diagnosis of HIV was 
made based on laboratory confirmation following a positive OraQuick ADVANCE® Rapid 
HIV-1/2 Antibody Tests. This rapid HIV antibody tests detects antibodies to HIV-1 and HIV-2 
within 20 minutes. Saliva was swabbed between the teeth and upper and lower gum by a 
certified HIV tester and counselor from the partner AIDS Service Organization.
Sexual Activity Investigator item Dichotomous variable to assess whether participants continued to engage in vaginal, anal 
and/or oral sex.
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Table 3.
Participant Demographic and Sexual Risk Characteristics at Baseline (N = 108)
Characteristic
Overall
Sample
(N = 108)
Assigned Condition
p*HIV
(N = 52)
GH
(N = 56)
Demographics
Age [Mean (SD)] [Median (IQR)] 15.78 (0.97)16.00 (15.0, 16.5)
15.81 (0.91)
16.00 (15.0, 16.0)
15.75 (1.03)
16.00 (15.0, 17.0) 0.76
Gender [N (%)] 0.92
Male 67 (62.0%) 32 (61.5%) 35 (62.5%)
Female 41 (38.0%) 20 (38.5%) 21 (37.5%)
Living Status [N (%)] 0.30
In a house that my parent/guardian owns 50 (46.3%) 28 (53.9%) 22 (39.3%)
In a house that my parent/guardian rents 44 (40.7%) 16 (30.8%) 28 (50.0%)
In an apartment that my parent/guardian rents 8 (7.4%) 5 (9.6%) 3 (5.4%)
In a shelter 2 (1.9%) 1 (1.9%) 1 (1.8%)
Other 4 (3.7%) 2 (3.9%) 2 (3.6%)
Grade in School [N (%)] 0.56
9th 23 (21.3%) 11 (21.2%) 12 (21.4%)
10th 38 (35.2%) 22 (42.3%) 16 (28.6%)
11th 22 (20.4%) 11 (21.2%) 11 (19.6%)
12th 16 (14.8%) 6 (11.5%) 10 (17.9%)
Other 4 (3.7%) 1 (1.9%) 3 (5.4%)
Missing 5 (4.6%) 1 (1.9%) 4 (7.1%)
Number of Adults in Household
[Mean (SD)] [Median (IQR)] (n = 103)
2.05 (1.13)
2.00 (1.0, 2.0)
2.20 (1.06)
2.00 (2.0, 3.0)
1.90 (1.19)
2.00 (1.0, 2.0) 0.19
Number of Children in Household
[Mean (SD)] [Median (IQR)] (n = 103)
2.62 (1.85)
2.00 (1.0, 4.0)
2.53 (1.83)
2.00 (1.0, 3.0)
2.71 (1.88)
2.00 (1.0, 4.0) 0.62
Family Income Compared to Others You Know
[N (%)] 0.55
A lot more than other people I know 7 (6.48%) 2 (3.9%) 5 (8.9%)
More than other people I know 20 (18.5%) 12 (23.1%) 8 (14.3%)
About the same as other people I know 60 (55.6%) 29 (55.8%) 31 (55.4%)
Less than other people I know 11 (10.2%) 6 (11.5%) 5 (8.9%)
A lot less than other people I know 1 (0.9%) 0 (0.0%) 1 (1.8%)
Missing 9 (8.3%) 3 (5.8%) 6 (10.7%)
Sexual Risk
Age at First Vaginal Sex [Mean (SD)]
[Median (IQR)] (n = 96)
13.56 (1.73)
14.00 (13.0, 15.0)
13.68 (1.99)
14.00 (13.0, 15.0)
13.46 (1.50)
14.00 (13.0, 15.0) 0.55
Age at First Anal Sex [Mean (SD)]
[Median (IQR)] (n = 17)
14.18 (1.42)
15.00 (13.0, 15.0)
14.09 (1.58)
15.00 (12.0, 15.0)
14.33 (1.21)
14.50 (13.0, 15.0) 0.73
Age at First Oral Sex [Mean (SD)]
[Median (IQR)] (n = 75)
13.51 (1.61)
14.00 (12.0, 15.0)
13.86 (1.40)
14.00 (12.0, 15.0)
13.20 (1.74)
14.00 (12.0, 14.5) 0.07
Number of Vaginal Sex Partners [Mean (SD)] [Median (IQR)] (n = 88) 5.48 (6.63)4.00 (2.0, 6.0)
4.40 (3.95)
3.00 (2.0, 5.5)
6.38 (8.16)
4.00 (2.0, 7.0) 0.15^
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Characteristic
Overall
Sample
(N = 108)
Assigned Condition
p*HIV
(N = 52)
GH
(N = 56)
Number of Anal Sex Partners [Mean (SD)]
[Median (IQR)] (n = 16)
1.75 (1.39)
1.00 (1.0, 2.0)
1.80 (1.55)
1.00 (1.0, 2.0)
1.67 (1.21)
1.00 (1.0, 2.0) 0.90^
Number of Oral Sex Partners [Mean (SD)]
[Median (IQR)] (n = 66)
5.03 (5.81)
3.00 (2.0, 5.0)
4.00 (4.11)
2.50 (1.0, 5.0)
5.89 (6.85)
3.00 (2.0, 7.5) 0.37^
How Often Condoms Were Used in the Past 3 Months [N (%)] 0.64
Never 13 (12.0%) 6 (11.5%) 7 (12.5%)
Sometimes 45 (41.7%) 19 (36.5%) 26 (46.4%)
Every time 44 (40.7%) 23 (44.2%) 21 (37.5)
Missing 6 (5.6%) 4 (7.7%) 2 (3.6%)
Proportion of Condom Use for Vaginal Sex
[Mean (SD)] [Median (IQR)] (n = 66)
0.66 (0.40)
1.00 (0.33, 1.0)
0.64 (0.42)
0.92 (0.2, 1.0)
0.67 (0.39)
1.00 (0.42, 1.0) 0.77^
Proportion of Condom Use for Anal Sex
[Mean (SD)] [Median (IQR)] (n = 13)
0.58 (0.45)
0.67 (0.0, 1.0)
0.65 (0.44)
0.83 (0.25, 1.0)
0.47 (0.51)
0.33 (0.0, 1.0) 0.58^
Proportion of Condom Use for Oral sex
[Mean (SD)] [Median (IQR)] (n = 53)
0.14 (0.34)
0.0 (0.0, 0.0)
0.13 (0.34)
0.0 (0.0, 0.0)
0.15 (0.35)
0.0 (0.0, 0.0) 0.74^
Sex with More Than One Person in the Same Month [N (%)] 0.02
Yes 49 (45.4%) 18 (34.6%) 31 (55.4%)
No 57 (52.8%) 34 (65.4%) 23 (41.1%)
Missing 2 (1.9%) 0 (0.0%) 2 (3.6%)
Sex with More Than One Person in the Same Day
[N (%)] 0.59
Yes 29 (26.9%) 13 (25.0%) 16 (28.6%)
No 77 (71.3%) 39 (75.0%) 38 (67.9%)
Missing 2 (1.9%) 0 (0.0%) 2 (3.6%)
Sex with Someone Else While in a Relationship
[N (%)] 0.10
Yes 37 (34.3%) 14 (26.9%) 23 (41.1%)
No 68 (63.0%) 37 (71.2%) 31 (55.4%)
Missing 3 (2.8%) 1 (1.9%) 2 (3.6%)
Number of Times You Had Sex with Someone Else While in a 
Relationship [Mean (SD)]
[Median (IQR)] (n = 31)
4.13 (8.14)
2.00 (2.0, 3.0)
3.09 (2.17)
2.00 (2.0, 4.0)
4.70 (10.06)
2.00 (2.0, 3.0) 0.67^
Number of Partners in the Past 6 Months
[Mean (SD)] [Median (IQR)] (n = 91)
3.04 (3.79)
2.00 (1.0, 3.0)
2.41 (2.96)
2.00 (1.0, 3.0)
3.64 (4.38)
2.00 (1.0, 4.0) 0.24^
Ever Been Tested for HIV [N (%)] 0.52
Yes 48 (44.4%) 25 (48.1%) 23 (41.1%)
No 59 (54.6%) 27 (51.9%) 32 (57.1%)
Missing 1 (0.9%) 0 (0.0%) 1 (1.8%)
Tested Positive for Chlamydia [N (%)] 0.74
Yes 10 (9.3%) 4 (7.7%) 6 (10.7 %)
No 98 (90.7%) 48 (92.3%) 50 (89.3%)
Tested Positive for Gonorrhea [N (%)] >.99
Yes 1 (0.9%) 0 (0.0%) 1 (1.8%)
No 107 (99.1%) 52 (100%) 55 (98.2%)
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Note. GH = General Health;
*p-values based on two-sample t-tests for normally distributed continuous variables, Fisher’s exact tests were used for categorical variables with 
cells containing less than 5 participants, and Chi-square tests for all other categorical variables;
^p-values based on non-parametric Wilcoxon Mann-Whitney test for non-normally distributed continuous variables.
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Table 5.
Participant Mental Health Diagnoses and Emotion Regulation by Assigned Conditions at Baseline (N = 108)
Measure
Overall
Sample
(N = 108)
Assigned Condition
p*HIV
(N = 52)
GH
(N = 56)
Mental Health Diagnoses
Total PHQ-9 Score [Mean (SD)]
[Median (IQR)] (n = 107)
2.92 (2.95)
2.00 (0.0, 5.0)
3.17 (2.82)
2.00 (1.0, 5.0)
2.67 (3.07)
2.00 (0.0, 4.0) 0.17^
Thoughts of Better Off Being Dead [N (%)] 0.80
Yes 3 (2.8%) 2 (3.9%) 1 (1.8%)
No 104 (96.3%) 50 (96.2%) 54 (96.4%)
Missing 1 (0.9%) 0 (0.0%) 1 (1.8%)
Current Panic Disorder without Agoraphobia [N (%)] 0.67
Yes 5 (4.6%) 3 (5.8%) 2 (3.6%)
No 103 (95.4%) 49 (94.2%) 54 (96.4%)
Current Agoraphobia without History of Panic Disorder [N (%)] 0.50
Yes 2 (1.9%) 0 (0.0%) 2 (3.6%)
No 106 (98.2%) 52 (100%) 54 (96.4%)
Panic Disorder with Current Agoraphobia [N (%)] >.99
Yes 1 (0.9%) 0 (0.0%) 1 (1.8%)
No 107 (99.1%) 52 (100%) 55 (98.2%)
Past Major Depressive Disorder [N (%)] 0.72
Yes 8 (7.4%) 3 (5.8%) 5 (8.9%)
No 100 (92.6%) 49 (94.2%) 51 (91.1%)
Current Major Depressive Disorder [N (%)] >.99
Yes 2 (1.9%) 1 (1.9%) 1 (1.8%)
No 106 (98.1%) 51 (98.1%) 55 (98.2%)
Recurrent Major Depressive Disorder [N (%)] 0.12
Yes 17 (15.7%) 5 (9.6%) 12 (21.4%)
No 91 (84.3%) 47 (90.4%) 44 (78.6%)
Suicidality [N (%)] 0.03
Yes 17 (15.7%) 4 (7.7%) 13 (23.2%)
No 91 (84.3%) 48 (92.3%) 43 (76.8%)
Suicidality (Rank) [N (%)] 0.11
Low (1 – 8 points) 16 (14.8%) 4 (7.7%) 12 (21.43%)
Moderate (9 – 16 points) 5 (4.6%) 2 (3.9%) 3 (5.4%)
Not Suicidal 87 (80.6%) 46 (88.5%) 41 (73.2%)
Past Manic Episode [N (%)] >.99
Yes 5 (4.6%) 2 (3.9%) 3 (5.4%)
No 103 (95.4%) 50 (96.2%) 53 (94.6%)
Past Hypomanic Episode [N (%)] >.99
Yes 4 (3.7%) 2 (3.9%) 2 (3.6%)
No 104 (96.3%) 50 (96.2%) 54 (96.4%)
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Measure
Overall
Sample
(N = 108)
Assigned Condition
p*HIV
(N = 52)
GH
(N = 56)
Past Hypomanic Symptoms [N (%)] >.99
Yes 7 (6.5%) 3 (5.8%) 4 (7.1%)
No 101 (93.5%) 49 (94.2%) 52 (92.9%)
Social Anxiety Disorder [N (%)] >.99
Yes 3 (2.8%) 1 (1.9%) 2 (3.6%)
No 105 (97.2%) 51 (98.1%) 54 (96.4%)
Current Obsessive-Compulsive Disorder [N (%)] 0.67
Yes 5 (4.6%) 3 (5.8%) 2 (3.6%)
No 103 (95.4%) 49 (94.2%) 54 (96.4%)
Post-Traumatic Stress Disorder [N (%)] 0.61
Yes 3 (2.8%) 2 (3.9%) 1 (1.8%)
No 105 (97.2%) 50 (96.2%) 55 (98.2%)
Alcohol Abuse [N (%)] >.99
Yes 1 (0.9%) 0 (0.0%) 1 (1.8%)
No 107 (99.1%) 52 (100%) 55 (98.2%)
Current Substance Dependence [N (%)] 0.06
Yes 5 (4.6%) 0 (0.0%) 5 (8.9%)
No 103 (95.4%) 52 (100%) 51 (91.2%)
Current Substance Abuse [N (%)] >.99
Yes 8 (7.4%) 4 (7.7%) 4 (7.1%)
No 100 (92.6%) 48 (92.3%) 52 (92.9%)
Lifetime Mood Disorder with Psychotic Features [N (%)] >.99
Yes 2 (1.9%) 1 (1.9%) 1 (1.8%)
No 106 (98.2%) 51 (98.1%) 55 (98.2%)
Current Mood Disorder with Psychotic Features [N (%)] 0.48
Yes 1 (0.9%) 1 (1.9%) 0 (0.0%)
No 107 (99.1%) 51 (98.1%) 56 (100%)
Current Psychotic Disorder [N (%)] 0.48
Yes 1 (0.9%) 1 (1.9%) 0 (0.0%)
No 107 (99.1%) 51 (98.1%) 56 (100%)
Lifetime Psychotic Disorder [N (%)] 0.48
Yes 1 (0.9%) 1 (1.9%) 0 (0.0%)
No 107 (99.1%) 51 (98.1%) 56 (100%)
Current Bulimia Nervosa [N (%)] >.99
Yes 2 (1.9%) 1 (1.9%) 1 (1.8%)
No 106 (98.1%) 51 (98.1%) 55 (98.2%)
Lifetime Antisocial Personality Disorder [N (%)] 0.67
Yes 5 (4.6%) 3 (5.8%) 2 (3.6%)
No 103 (95.4%) 49 (94.2%) 54 (96.4%)
Emotion Regulation
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Measure
Overall
Sample
(N = 108)
Assigned Condition
p*HIV
(N = 52)
GH
(N = 56)
CEM Anger Subscales [Mean (SD)]
[Median (IQR)]
Inhibition (n = 107) 1.96 (0.52)2.00 (1.5, 2.25)
2.03 (0.53)
2.00 (1.75, 2.5)
1.91 (0.51)
1.88 (1.50, 2.25) 0.22
Dysregulation (n = 107) 1.73 (0.56)1.67 (1.33, 2.0)
1.76 (0.62)
1.67 (1.33, 2.33)
1.70 (0.51)
1.67 (1.33, 2.0) 0.57
Coping (n = 107) 2.22 (0.48)2.25 (2.0, 2.5)
2.24 (0.52)
2.25 (2.0, 2.75)
2.20 (0.45)
2.00 (2.0, 2.5) 0.68
CEM Sadness Subscales [Mean (SD)]
[Median (IQR)]
Inhibition (n = 108) 2.08 (0.61)2.00 (1.75, 2.5)
2.09 (0.63)
2.00 (1.5, 2.63)
2.07 (0.59)
2.00 (1.75, 2.5) 0.84
Dysregulation (n = 106) 1.43 (0.47)1.33 (1.0, 1.67)
1.42 (0.47)
1.33 (1.0, 1.67)
1.44 (0.47)
1.33 (1.0, 1.67) 0.85
Coping (n = 104) 2.27 (0.49)2.20 (2.0, 2.6)
2.23 (0.50)
2.20 (1.8, 2.6)
2.31 (0.48)
2.20 (2.0, 2.6) 0.40
Note. GH = General Health;
*p-values based on two-sample t-tests for normally distributed continuous variables, Fisher’s exact tests were used for categorical variables with 
cells containing less than 5 participants, and Chi-square tests for all other categorical variables;
^p-values based on non-parametric Wilcoxon Mann-Whitney test for non-normally distributed continuous variables
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